Literature DB >> 26696529

Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Eveli Kallas1, Kristi Huik2, Silver Türk2, Merit Pauskar2, Ene-Ly Jõgeda2, Marina Šunina3, Tõnis Karki2, Don Des Jarlais4, Anneli Uusküla5, Radko Avi2, Irja Lutsar2.   

Abstract

Some individuals remain uninfected despite repeated exposure to HIV. This protection against HIV has been partly associated with altered T cell subset distributions and CCR5 expression levels. However, the majority of studies have been conducted in sexually exposed subjects. We aimed to assess whether HIV infection and intravenous drug use were associated with differences in CCR5 expression, immune activation on the CD4+ and CD8+ T cells and T cell distribution among Caucasian persons who inject drugs (PWIDs). Analyses of the data from 41 HIV-positive PWIDs, 47 HIV-exposed seronegative PWIDs (ESNs) and 47 age- and gender-matched HIV-negative non-drug users are presented. Of all of the study subjects, 111 (82 %) were male, and the median age was 29 years. T cell phenotyping was performed in peripheral blood mononuclear cells with multicolour flow cytometry using anti-CD3, CD4, CD8, CD45RA, CD45RO, HLA-DR and CCR5 antibodies. The ESNs exhibited greater levels of immune activation and higher percentages of CD4+ CD45RA+RO+ and CD8+ CD45RA+RO+ cells compared to the controls but not the HIV-positive people. The CCR5 expression on the CD4+ T cell subsets in the ESNs was lower than that in the controls but similar to that the HIV positives. The percentages of CCR5+ T cells were similar in all study groups and in most of the studied cell populations. Intravenous drug use was similarly associated with differences in T cell subset distributions and CCR5 expression among both the HIV-positive and HIV-negative PWIDs compared with the controls.

Entities:  

Keywords:  HIV susceptibility; IDU; Immunological profile; Inflammation; Opiates; T cell subset

Mesh:

Substances:

Year:  2015        PMID: 26696529     DOI: 10.1007/s00430-015-0444-8

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  43 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men.

Authors:  Susan M Thomas; Doris B Tse; D Scott Ketner; Gemma Rochford; Daniel A Meyer; David D Zade; Perry N Halkitis; Arthur Nádas; William Borkowsky; Michael Marmor
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

4.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

Review 5.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

6.  Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men.

Authors:  M Scott Killian; Joanita Monteiro; Jose Matud; Lance E Hultin; Mary Ann Hausner; Otto O Yang; Peter K Gregersen; Roger Detels; Janis V Giorgi; Beth D Jamieson
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

7.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

Authors:  Amber D Steele; Earl E Henderson; Thomas J Rogers
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

8.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

9.  Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users.

Authors:  Kristi Huik; Radko Avi; Merit Pauskar; Eveli Kallas; Ene-Ly Jõgeda; Tõnis Karki; Kristina Marsh; Don Des Jarlais; Anneli Uusküla; Irja Lutsar
Journal:  Infect Genet Evol       Date:  2013-08-17       Impact factor: 3.342

10.  High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.

Authors:  Anneli Uusküla; Louise Anne McNutt; Jack Dehovitz; Krista Fischer; Robert Heimer
Journal:  Int J STD AIDS       Date:  2007-01       Impact factor: 1.359

View more
  4 in total

1.  Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.

Authors:  Sherry Deren; Charles M Cleland; Haekyung Lee; Saurabh Mehandru; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

2.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

3.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Viral Immunol       Date:  2016-08-26       Impact factor: 2.257

4.  Enhanced Signaling Through the TLR9 Pathway Is Associated With Resistance to HIV-1 Infection in Chinese HIV-1-Exposed Seronegative Individuals.

Authors:  Junjun Jiang; Xi Hu; Wenwei Li; Jie Liu; Bingyu Liang; Hui Chen; Jiegang Huang; Ning Zang; Chuanyi Ning; Yanyan Liao; Rongfeng Chen; Jingzhen Lai; Jiemei Chu; Peijiang Pan; Ping Cui; Qiao Tang; Xiu Chen; Hao Liang; Li Ye
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.